GlobeNewswire by notified

Philips and Vanderbilt University Medical Center unite to define roadmap for decarbonizing radiology

Share

May 22, 2023

Amsterdam, the Netherlands and Nashville, TN, USARoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Vanderbilt University Medical Center (VUMC), home to the top-ranked adult and pediatric hospitals in the Southeastern U.S., today announced a collaboration that aims to reduce the health system’s carbon footprint while determining a blueprint to guide industry efforts. The project is with the radiology department, where efforts will focus on measuring and addressing energy consumption of VUMC’s diagnostic imaging devices including MR, CT, ultrasound and X-ray. The two organizations plan to publish their findings with the aim of promoting knowledge exchange and enabling others in the industry to enhance their environmental strategies.

The healthcare industry is responsible for an estimated 7.6% of U.S. and 4.4% of global emissions [1]; with its heavy energy, equipment, and supply usage, radiology is a significant contributor to the CO2 emissions responsible for climate change [2]. Philips will work with VUMC to collect a range of equipment lifecycle data, including radiology data and measurements of the equipment energy consumption, analyze operational workflow efficiency and interview VUMC staff and faculty to build computational models on which to run simulations. The teams will then summarize piloted interventions to test the reduction of the department’s carbon footprint.

“We consider climate care as healthcare. Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity, it’s also a responsibility. The future of radiology requires us to be cognizant, aware and proactive about addressing this issue which directly affects the communities we live in and the patients we treat,” said Reed Omary, MD, MS, Carol D. and Henry P. Pendergrass Professor and Chair of Radiology at Vanderbilt University Medical Center. “We have a collective responsibility to help mitigate climate change, which is why we’ve entered into this collaboration. Working together will allow us to leverage Philips’ general healthcare and specific radiology expertise – as well as their own success in achieving CO2 net-zero operations – to make important reductions in our carbon footprint.”

In addition to financial costs for a given diagnosis, VUMC’s Department of Radiology and Radiological Sciences understands that there is also an additional carbon cost to make that diagnosis. Philips brings knowledge and a longstanding commitment to sustainability to the collaboration. Recently, Philips became the first health technology company to have its entire value-chain CO₂ emissions reduction targets approved by the Science Based Targets initiative (SBTi) with strategic action plans in place. The company has reported solid progress in reducing CO2 emissions across its innovations and supply chain, and has operated globally carbon neutral since 2020. Philips builds on decades of experience reducing energy consumption, waste, and materials and substances usage by embedding its EcoDesign criteria and circular business models across product innovation and ways of working. Through digitalization and collaboration, the company actively seeks to expand access to care, while working closely with customers and partners to improve the environmental impact of in-use diagnostic imaging technology.

“Philips and VUMC share a common vision – that systemically addressing climate change is going to take commitment and collaboration across the industry. Philips’ 2023 Future Health Index found that nearly half of U.S. healthcare leaders are planning to overcome challenges to implementing sustainability initiatives by sharing best practices and learnings from peers,” said Jeff DiLullo, chief region leader, Philips North America. “We are optimistic that results from this partnership will not only assist Vanderbilt in its effort to understand and address carbon emissions in its own radiology department, but serve as a model for others seeking to decarbonize their operations.”

[1] https://noharm-global.org/sites/default/files/documents-files/5961/HealthCaresClimateFootprint_092319.pdf
[2] https://www.researchgate.net/publication/366649243_Climate_Change_Carbon_Dioxide_Emissions_and_Medical_Imaging_Contribution

For further information, please contact:

Avi Dines

Philips North America
Tel: + 1 781 690 3814
Email: avi.dines@philips.com

Mark Groves
Philips Global Press Office
Tel: +31 631 639 916
Email: mark.groves@philips.com

Vanderbilt Radiology Communications (please contact both):
Derek Scancarelli
Senior Communications Specialist
derek.scancarelli@vumc.org

Jackson Hicks
Associate Communications Specialist
Jackson.hicks@vumc.org

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 74,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

About Vanderbilt University Medical Center
Vanderbilt University Medical Center (VUMC) is the largest comprehensive research, teaching and patient care health system in the Mid-South region, with the highest ranked adult and children’s hospitals in the Southeast by U.S. News & World Report. Based in Nashville, Tennessee, VUMC sees over 3 million patient visits per year in over 200 ambulatory locations, performs 88,000 surgical operations and discharges 80,000 inpatients from its main-campus adult, children’s, psychiatric and rehabilitation hospitals and three regional community hospitals. The Medical Center is the largest non-governmental employer of Middle Tennesseans, with nearly 40,000 staff, including more than 3,000 physicians, advanced practice nurses and scientists appointed to the Vanderbilt University faculty. For more information and the latest news follow VUMC on FacebookLinkedInTwitter and in the VUMC Reporter.

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Correction to Company announcement – No. 23 / 202419.4.2024 22:20:51 CEST | Press release

Correction to Company announcement – No. 23 / 2024 Copenhagen, Denmark, April 19, 2024 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has a correction to company announcement No. 23 /2024, April 19, 2024 - regarding transactions in Zealand’s shares or related securities conducted by persons discharging managerial responsibilities and/or their closely associated persons it was reported that member of the management, Henriette Wennicke, was allocated a total of 8,008 restricted stock units with a total value of DKK 9,577,568.00. The correct number was a total of 8,008 restricted stock units with a total value of DKK 4,788,784.00. Please see the attached file(s). # # # About Zealand Pharma A/S Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10

Nokia Corporation: Repurchase of own shares on 19.04.202419.4.2024 21:30:00 CEST | Press release

Nokia Corporation Stock Exchange Release 19 April 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 19.04.2024 Espoo, Finland – On 19 April 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL430,8933.30CEUX--BATE--AQEU--TQEX--Total430,8933.30 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of

Landsbankinn hf.: Results of the 2024 AGM of Landsbankinn19.4.2024 20:48:08 CEST | Press release

The annual general meeting (AGM) of Landsbankinn, held on 19 April 2024, agreed to pay a dividend amounting to ISK 16,535 million to shareholders. The dividend is equivalent to 50% of 2023 profits. The dividend will be paid in two instalments, firstly on 24 April 2024 and secondly on 16 October 2024. As a result, total dividend paid by the Bank in 2013-2024 amounts to ISK 191.7 billion. At the AGM, held in Reykjastræti 6, Helga Björk Eiríksdóttir, Chairman of the Board of Directors, delivered the report from the Board for 2023. Lilja Björk Einarsdóttir, CEO, spoke of the Bank’s operation, strategy and activities in the past operating year. The annual financial statement for the past operating year was approved, as was the proposed Remuneration Policy and remuneration to Directors of the Board. The AGM elected the Auditor General (Ríkisendurskoðun) as auditor of Landsbankinn hf. for the 2024 operating year. The Auditor General, in accordance with an authorisation to outsource tasks, and

SKEL fjárfestingafélag hf.: Styrkás finalizes the purchase of Stólpi Gámar ehf. and affiliated companies.19.4.2024 19:20:57 CEST | Press release

Reference is made to the announcement dated 31 January 2024, regarding Styrkás hf., a company 69.64% owned by SKEL fjárfestingafélag hf., signing a purchase agreement to acquire 100% of the shares in six subsidiaries of Máttarstólpi ehf. The purchase agreement was subject to the approval of the Competition Authority. The transaction was finalized today with payment of purchase price and delivering of shares in the following companies: - Stólpi Gámar ehf., id. 460121-1590, Klettagörðum 5, 104 Reykjavík: - Stólpi Smiðja ehf., id. 460121-1750, Klettagörðum 5, 104 Reykjavík; - Klettskjól ehf., id. 460121-0510, Klettagörðum 5, 104 Reykjavík; - Stólpi ehf., 460121-0430, Klettagörðum 5, 104 Reykjavík; - Tjónaþjónustan ehf., id. 460121-1670, Klettagörðum 5, 104 Reykjavík; - Alkul ehf., id. 491020-0830, Haukdælabraut 48, 113 Reykjavík. collectively referred to as "the sold companies". These companies will continue to be operated on a consolidated basis. The Enterprise value of the sold companie

HiddenA line styled icon from Orion Icon Library.Eye